NORTHERN TRUST CORP - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$29,472
-22.5%
42,193
-0.1%
0.00%
Q4 2022$38,009
-85.0%
42,232
-0.1%
0.00%
Q3 2022$254,000
+61.8%
42,269
+11.4%
0.00%
Q2 2022$157,000
+6.1%
37,935
-2.1%
0.00%
Q1 2022$148,000
-16.4%
38,758
-1.3%
0.00%
Q4 2021$177,000
+18.0%
39,286
+22.0%
0.00%
Q3 2021$150,000
-12.3%
32,198
+32.5%
0.00%
Q2 2021$171,000
-73.4%
24,300
-77.7%
0.00%
Q1 2021$642,000
+13.4%
108,736
-11.4%
0.00%
Q4 2020$566,000
+17.7%
122,740
-0.7%
0.00%
Q3 2020$481,000
-86.8%
123,574
-2.7%
0.00%
-100.0%
Q2 2020$3,652,000
+186.9%
127,006
+114.7%
0.00%
Q1 2020$1,273,000
+21.7%
59,154
+11.3%
0.00%
Q4 2019$1,046,000
+905.8%
53,146
+663.5%
0.00%
Q3 2019$104,0006,9610.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CAXTON CORP 870,820$13,071,00014.74%
RA Capital Management 4,681,858$70,275,0004.19%
Cormorant Asset Management, LP 858,382$12,884,0000.78%
Monashee Investment Management LLC 62,500$938,0000.43%
TPG Group Holdings (SBS) Advisors, Inc. 3,771,878$56,616,0000.42%
DC Investments Management, LLC 35,502$533,0000.31%
Eventide Asset Management 425,000$6,379,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 610,000$9,156,0000.02%
Weiss Asset Management LP 14,150$212,0000.02%
Zimmer Partners, LP 100,000$1,501,0000.02%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders